Navigation Links
AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
Date:4/4/2013

rheumatoid arthritis and an alternative to injectable therapies for patients with an inadequate response to conventional Disease Modifying Anti-Rheumatic Drugs (DMARDs), including methotrexate (OSKIRA-1 and OSKIRA-2) and those with an inadequate response to TNF-α antagonists (OSKIRA-3).

About FostamatinibFostamatinib (previously referred to as R788) is the first oral spleen tyrosine kinase (SYK) inhibitor in development for rheumatoid arthritis. In February 2010, AstraZeneca and Rigel Pharmaceuticals announced a worldwide license agreement whereby AstraZeneca would develop and commercialize fostamatinib.

About Rheumatoid Arthritis (RA)Rheumatoid arthritis is a systemic autoimmune disease whereby the immune system attacks the joints, causing pain, swelling to the surrounding tissue and damage to the cartilage and bone. The disease affects approximately one in 100 people worldwide. 

If not adequately treated, RA can destroy cartilage and bone within joints, leading to serious disability and can be associated with reduced life expectancy. Not all RA patients have a satisfactory response to existing therapies because the disease pathology may differ from one individual to another and a considerable unmet need remains.

In the US alone the total annual societal cost of RA is estimated to amount to $39.2 billion, with even greater indirect costs to individuals and society including costs from diminished work capacity, loss of productivity, loss in earnings and loss in tax contributions.

About Rigel Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signalling pathways and related targets that are critical to disease
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
2. AstraZeneca And Cellworks Collaborate To Find New Treatment For Tuberculosis
3. Genpact and AstraZeneca Win Outsourcing Center and SSON Awards
4. AstraZeneca Acquires Neuroscience Assets From Link Medicine
5. AstraZeneca and Leading Academic Scientists to Collaborate on Alzheimers Disease Research
6. Founded by Enlight Biosciences, KNODE partners with AstraZeneca and Other Partners
7. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
8. AstraZeneca And The Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents
9. Isis Pharmaceuticals And AstraZeneca Form Strategic Alliance On RNA Therapeutics For Cancer
10. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
11. AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- Reportlinker.com announces that a new market research report is ... Taiwanese Markets for Minimally Invasive Spinal Devices ... market for MIS spinal devices in the ... a fast pace, albeit at different rates in different ... China , where MIS spinal fusion is ...
(Date:9/2/2014)... commands the vital signs monitoring devices market with over ... . The North American and European vital signs monitors ... million, respectively, by the end of 2013. They have ... number of elderly people across these economies. The European ... owing to the rising demand for home health patient ...
(Date:9/2/2014)... 2014 According to a ... "Latin America Home Healthcare Market (By Device Types: ... Mobility Assist Devices and Medical Supplies; By Services: ... and Unskilled Home Healthcare Services) - Industry Analysis, ... 2020" the Latin American Home Healthcare market was ...
Breaking Medicine Technology:Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 2Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 3Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 4Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 5Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 6Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 7Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 8Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 9Market of Vital Signs Monitoring Devices Forecast to 2018 2Market of Vital Signs Monitoring Devices Forecast to 2018 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... Oct. 9 Vical Incorporated,(Nasdaq: VICL ) ... mice demonstrated,the potential of its patented Vaxfectin(TM) adjuvant ... protein-based H5N1 pandemic influenza vaccine,currently stockpiled by the ... limited vaccine supplies to protect the greatest,number of ...
... Oct. 9 The Wellion Linus Blood Glucose,Monitoring ... recently received certification by the Netherlands Organization,for Applied ... group,founded in 1932 that thoroughly tests and inspects ... the CE Marking. "Receiving the TNO approval ...
Cached Medicine Technology:Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 2Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 3Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 4WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests 2
(Date:9/2/2014)... The Dream2Walk Foundation along with Gas Monkey Bar and Grill ... Cord Injury Awareness Month featuring full band performances by Zane ... Automotive will be there hosting a Hot Rod, Rat Rod, ... The car show is Pre 1964 only, with a $50.00 ... There will be trophies for top 3 and best of ...
(Date:9/2/2014)... HealthDay Reporter TUESDAY, ... such as Adderall, Ritalin and Concerta -- used to ... growth, a new study suggests. "Stimulant medication did ... researcher Dr. Slavica Katusic, an associate professor of pediatrics ... noted that results of earlier studies have been mixed, ...
(Date:9/2/2014)... (HealthDay News) -- Drinking and marijuana may lead to ... study suggests. Researchers analyzed 2007 to 2011 data ... who said they had used alcohol or marijuana at ... was associated with more unsafe driving, damage to relationships ... while under the influence of alcohol, especially among females. ...
(Date:9/2/2014)... sleep apnea, tonsillectomies, hearing loss, head and neck ... in Orlando, FL, September 21-24, at the 2014 ... Academy of OtolaryngologyHead and Neck Surgery Foundation (AAO-HNSF), ... head and neck physicians in the world. , ... released today, and are available online at ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Last year, ... level with the launch of a luxurious line of graduated ... that the SEA ISLAND COTTON Socks are joining the SIGVARIS ... giving more people the comfort of natural cotton fibers. ... they are surprised to find socks as soft as the ...
Breaking Medicine News(10 mins):Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 2Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 3Health News:Booze, Pot Bad for Teens in Different Ways, Study Suggests 2Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2
... (HealthDay News) -- Chemicals called phthalates and bisphenol-A (BPA) ... products may alter levels of thyroid hormones in the ... hormones play a role in many critical bodily functions, ... of Michigan School of Public Health used data from ...
... Reporter , WEDNESDAY, July 13 (HealthDay News) -- Top ... air traffic controllers napping on the job are missing ... Studies have shown that short "power naps" have ... for people impaired by drowsiness, said Dr. Alon Avidan, ...
... be admirable or romantic. In a cancerous tumor, it may ... that have strayed from their original location to insinuate their way ... of determining whether a newly formed tumor is more likely to ... body. In a study published in the July 12 issue ...
... July 14 (HealthDay News) -- Binge drinking may not necessarily ... new animal study suggests. But it can block key ... that interferes with brain functions critical to learning and memory, ... Medicine in St. Louis argued their findings not only shed ...
... essential for the regulation of important biological processes such ... shows that BK channel activation involves structural rearrangements formerly ... issue of the Journal of General Physiology ... possible unified theory of activation gating in K+ channels, ...
... cardiologists are prone to misinterpreting electrocardiograms when using ... heart defects that could make exercising perilous, according ... School of Medicine and Lucile Packard Children,s Hospital. ... acumen of pediatric cardiologists from several health-care institutions ...
Cached Medicine News:Health News:Exposure to Common Chemicals May Affect Thyroid Function 2Health News:Sometimes Sleeping on the Job May Be a Good Thing 2Health News:Sometimes Sleeping on the Job May Be a Good Thing 3Health News:Early-stage melanoma tumors contain clues to metastatic potential 2Health News:Early-stage melanoma tumors contain clues to metastatic potential 3Health News:Rat Study Shows How Binge Drinking Harms Memory 2Health News:Pediatric cardiologists not always accurate in interpreting ECG results for young athletes 2Health News:Pediatric cardiologists not always accurate in interpreting ECG results for young athletes 3
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
... The efficacy of treating upper ... been documented in many studies. , ... Humeral Nail System offers the benefits ... limited soft tissue dissection and early ...
... the worlds leading medical technology company ... management for more than a decade, ... Timer. The ACT Plus System is ... to determine coagulation endpoints in whole ...
... techniques have largely replaced the use of plates and ... use of rods or pins in the forearm or ... been no way to lock the pins or hold ... non-locked nail is back out of the implant. The ...
Medicine Products: